Our Impact
We are Engineering the Future of Healthcare. Pioneering genetic medicine that heals patients, protects the planet, and powers progress for all.
For 25 years, we have pioneered breakthroughs that redefine what’s possible in healthcare.
Transforming Lives Through Genetic Medicine. Our work transcends laboratory walls – we deliver measurable, life-changing impact for patients, clinicians, and the entire medical community. We prioritize the highest quality standards for more transparent, ethical, and resilient operations — from governance and workforce to human rights and supply chain responsibility.
1
+
Active clinical
trials
trials
1
b
Customer Satisfaction
is Our Success
is Our Success
1
k
Active patent
matters
matters
1
m
donated by Bioevance
the Bioevance Foundation
the Bioevance Foundation
We Always Work With The Highest Responsibility
Transformative Impact in Genetic Medicine
Pioneering Patient Breakthroughs, Scientific Advancement & Global Health Equity
1,200+ patients treated with our FDA/EMA-approved gene therapies for rare diseases
83% improvement in quality-of-life metrics across our clinical trial participants
5 formerly fatal conditions now have approved treatments thanks to our research
50+ patents granted for novel genetic editing and delivery technologies
180+ peer-reviewed publications in journals including Nature Genetics and The Lancet
12 ongoing international collaborations with top research institutions
Trained 400+ clinicians in precision medicine applications
Reduced diagnostic odysseys from 5 years to 6 months for rare disease patients
Contributed to 3 new NHS treatment guidelines for genetic disorders
First carbon-neutral genetic medicine research facility in Europe
100% ethical sourcing for all biomaterials
£2.3 million invested annually in community genetic literacy programs
15+ low-income countries receiving subsidized access to our genetic diagnostics
£1.8 million donated annually to expand gene therapy access in developing nations
Open-source research portal providing free genomic tools to 8,000+ researchers worldwide
First biotech company to implement WHO's Fair Pricing Framework for rare disease treatments
